ストックスクリーナーアプリを入手
3.10
1.31%
0.04
アフターアワーズ：
3.25
0.15
+4.84%
前日終値:
$3.06
開ける：
$3.07
24時間の取引高:
515.84K
Relative Volume:
0.51
時価総額：
$270.75M
収益：
-
当期純損益:
$-95.90M
株価収益率:
-2.3485
EPS:
-1.32
ネットキャッシュフロー:
$-79.09M
1週間 パフォーマンス:
+5.44%
1か月 パフォーマンス:
-0.32%
6か月 パフォーマンス:
-50.32%
1年 パフォーマンス:
-54.07%
1日の値動き範囲:
$3.06
$3.165
1週間の範囲:
$2.84
$3.17
52週間の値動き範囲:
$1.865
$11.40
Terns Pharmaceuticals Inc Stock (TERN) Company Profile
名前
Terns Pharmaceuticals Inc
セクター
電話
650-525-5535 EXT.101
住所
1065 EAST HILLSDALE BLVD., SUITE 100, FOSTER CITY
TERN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TERN
Terns Pharmaceuticals Inc
|
3.10 | 256.77M | 0 | -95.90M | -79.09M | -1.32 |
|
ONC
Beone Medicines Ltd Adr
|
246.68 | 25.81B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
447.09 | 111.46B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.30 | 40.37M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
605.39 | 64.44B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
77.49 | 6.19B | 0 | -153.72M | -103.81M | -2.00 |
Terns Pharmaceuticals Inc Stock (TERN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-02-28 | 開始されました | William Blair | Mkt Perform |
| 2024-10-31 | 開始されました | Oppenheimer | Outperform |
| 2023-06-22 | 開始されました | Mizuho | Buy |
| 2023-06-07 | 開始されました | Jefferies | Buy |
| 2023-05-31 | 開始されました | ROTH MKM | Buy |
| 2023-05-08 | 開始されました | BMO Capital Markets | Outperform |
| 2023-02-14 | 開始されました | JMP Securities | Mkt Outperform |
| 2023-02-07 | 開始されました | UBS | Buy |
| 2022-09-12 | 開始されました | H.C. Wainwright | Neutral |
| 2021-09-14 | 再開されました | Goldman | Buy |
| 2021-03-02 | 開始されました | Cowen | Outperform |
| 2021-03-02 | 開始されました | Goldman | Buy |
| 2021-03-02 | 開始されました | JP Morgan | Overweight |
すべてを表示
Terns Pharmaceuticals Inc (TERN) 最新ニュース
Terns Pharmaceuticals to Participate in Upcoming June Investor C - GuruFocus
Terns Pharmaceuticals Secures Double Speaking Slots at Major Healthcare Conferences: What to Expect - Stock Titan
Terns Pharmaceuticals to Participate in Upcoming June Investor Conferences - GlobeNewswire
D. E. Shaw & Co. Inc. Increases Stock Holdings in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
Millennium Management LLC Has $8.92 Million Stock Holdings in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
Terns Pharmaceuticals’ SWOT analysis: promising pipeline drives stock potential By Investing.com - Investing.com Nigeria
Nuveen Asset Management LLC Buys 617,009 Shares of Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
Terns Pharmaceuticals’ SWOT analysis: promising pipeline drives stock potential - Investing.com
Northern Trust Corp Has $3.28 Million Stake in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
Deutsche Bank AG Has $2.21 Million Position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
BNP Paribas Financial Markets Acquires New Holdings in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
Cubist Systematic Strategies LLC Decreases Position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Shares Sold by The Manufacturers Life Insurance Company - Defense World
BMO Capital Markets Issues Pessimistic Forecast for Terns Pharmaceuticals (NASDAQ:TERN) Stock Price - Defense World
Terns Pharmaceuticals Selected for Oral Presentation at - GlobeNewswire
Terns Pharmaceuticals Selected for Oral Presentation at European - GuruFocus
Terns Pharmaceuticals Selected for Oral Presentation at European Hematology Association Congress For Preclinical Data on Novel Allosteric BCR-ABL Inhibitor TERN-701 - The Manila Times
Terns Pharmaceuticals Selected for Oral Presentation at European Hematology Association ... - Bluefield Daily Telegraph
Breakthrough: New Leukemia Drug TERN-701 Outperforms Standard Treatment in Multiple Resistance Cases - Stock Titan
Terns Pharma (TERN) Price Target Lowered by BMO Capital | TERN S - GuruFocus
Pfizer (PFE): Patent Developments Affect Terns Pharmaceuticals | PFE Stock News - GuruFocus
Pfizer (PFE): Patent Developments Affect Terns Pharmaceuticals | - GuruFocus
Terns Pharmaceuticals Reports Q1 2025 Financial Results - TipRanks
Dimensional Fund Advisors LP Raises Stake in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
Hsbc Holdings PLC Grows Position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
Is Terns Pharmaceuticals, Inc. (TERN) the Low Risk High Reward Stock Set to Triple by 2030? - Insider Monkey
Terns Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Corporate Updates - GlobeNewswire
10 Low Risk High Reward Stocks Set to Triple by 2030 - Insider Monkey
Terns (TERN) Advances Clinical Programs with Promising Developme - GuruFocus
BRIEF-Terns Pharmaceuticals Q1 Net Income USD -23.908 Million - TradingView
Wells Fargo & Company MN Has $227,000 Stock Position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
MetLife Investment Management LLC Acquires 9,500 Shares of Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
JPMorgan Chase & Co. Reduces Stake in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) - The Manila Times
Terns Pharmaceuticals Reports Inducement Grants to New Employees - GuruFocus
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) | TERN Stock News - GuruFocus
Biotech Firm Terns Awards Massive 325,000 Share Options Package to New Key Hires - Stock Titan
What is Terns Pharmaceuticals Inc (TERN) Stock Return on Shareholders’ Capital? - Sete News
Terns Pharmaceuticals Inc (TERN) deserves deeper analysis - uspostnews.com
Terns Pharmaceuticals to Participate in The Citizens Life Sciences Conference - The Manila Times
Terns Pharma Leaders to Reveal Latest Oncology and Obesity Drug Pipeline Updates at Major Conference - Stock Titan
An Analysis of Terns Pharmaceuticals Inc (TERN)’s Potential Price Growth - knoxdaily.com
Terns Pharmaceuticals Inc’s: Contrasting Stock Performances in a Volatile Market - investchronicle.com
Terns Pharmaceuticals Inc (NASDAQ: TERN) Stock Could Make A -543.09% Loss - Marketing Sentinel
Analyzing Ratios: Terns Pharmaceuticals Inc (TERN)’s Financial Story Unveiled - DWinneX
Market Resilience: Terns Pharmaceuticals Inc (TERN) Finishes Weak at 2.10, Down -9.87 - DWinneX
A Look at Terns Pharmaceuticals Inc (TERN) Shares in the Recent Past Indicates Growth - Sete News
TERN overperforms with a 2.86 increase in share price - uspostnews.com
Geode Capital Management LLC Has $8.40 Million Holdings in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
A company insider recently sold 952 shares of Terns Pharmaceuticals Inc [TERN]. Should You also Consider to Sale? - knoxdaily.com
An Analysis Of Terns Pharmaceuticals Inc (TERN) Stock - Marketing Sentinel
Terns Pharmaceuticals Inc (TERN) 財務データ
収益
当期純利益
現金流量
EPS
0.95%
大文字化:
|
ボリューム (24 時間):